The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents
Abstract
Objective.: To compare the efficacy and tolerability of sumatriptan nasal spray (NS; 5 mg, 10 mg, and 20 mg) with placebo for the treatment of acute migraine in adolescents. Methods.: A randomized, double-blind, placebo-controlled, single-attack study was conducted in 653 US adolescents (12–17 years of age). Patients with at least a 6-month history of migraine, who met International Headache Society criteria for migraine (with or without aura) were eligible for participation. Headache relief 2 hours postdose, complete relief, presence or absence of associated symptoms, headache recurrence, and use of rescue medications were recorded. The primary efficacy endpoint was headache relief 2 hours postdose sumatriptan NS (20 mg) versus placebo. Safety and tolerability were assessed by examining adverse events, changes in electrocardiograms, vital signs, physical examinations, and clinical laboratory tests. Results.: Headache relief 1 hour postdose was significantly greater for patients using 10 mg (56%) and 20 mg (56%) of sumatriptan NS compared with placebo (41%). Headache relief 2 hours postdose was significantly greater for patients using 5 mg of sumatriptan NS (66%) compared with placebo (53%), and approached statistical significance for 20 mg (63%) compared with placebo (53%). Complete relief 2 hours postdose was significantly greater for patients using 20 mg of sumatriptan NS compared with placebo (36% vs 25%, respectively). Each dose of sumatriptan (5 mg, 10 mg, and 20 mg) was superior to placebo with respect to the cumulative percentages of patients first reporting headache relief within 2 hours of dosing (Kaplan-Meier). The sumatriptan 20-mg dose was superior to placebo with respect to the cumulative percentages of patients first reporting complete relief within 2 hours of dosing (Kaplan-Meier). Photophobia and phonophobia were significantly reduced 2 hours postdose for sumatriptan NS (20 mg), compared with placebo (36% vs 48% and 25% vs 44%, respectively). Taste disturbance was the most commonly reported adverse event (2%, 19%, 30%, and 26% for placebo, 5 mg, 10 mg, and 20 mg, respectively). No drug-related serious adverse events or clinically relevant changes in laboratory parameters, electrocardiograms, or vital signs were reported. Conclusions.: Sumatriptan NS is effective and well-tolerated for the treatment of acute migraine in adolescents, with the 20-mg dose providing the best overall efficacy and tolerability profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,465
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel-Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500879 · Cited by 2,897
The Importance of Placebo Effects in Pain Treatment and Research
Turner, J. A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510440069036 · Cited by 874
Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250504 · Cited by 448
A gene for familial hemiplegic migraine maps to chromosome 19
Joutel, A., Bousser, M.-G., Biousse, V., Labauge, P., Chabriat, H., Nibbio, A., Maciazek, J., Meyer, B., Bach, M.-A., Weissenbach, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0993-40 · Cited by 388
An Epidemiologic Study of Headache Among Adolescents and Young Adults
Linet, M. S. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420150061038 · Cited by 347
Treatment of Acute Migraine With Subcutaneous Sumatriptan
Cady, R. K. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460210077033 · Cited by 318
Changes in the Prevalence of Migraine and Other Headaches During the First Seven School Years
Sillanpää, M. (1983) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1983.hed2301015.x · Cited by 299
Treatment of migraine attacks with sumatriptan
Milne, L. (1992) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(92)90247-q · Cited by 252
An Epidemiologic Study of Headache Among Children and Adolescents of Southern Brazil
Barea, L., Tannhauser, M., & Rotta, N. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1608545.x · Cited by 174
Intranasal sumatriptan for the acute treatment of migraine in children
Ueberall, M. A., & Wenzel, D. (1999) · Neurology · doi:10.1212/wnl.52.7.1507 · Cited by 171
May, A., Ophoff, R. A., Terwindt, G. M., Urban, C., van Eijk, R., Haan, J., Diener, H. C., Lindhout, D., Frants, R. R., Sandkuijl, L. A., et al. (1995) · Human Genetics · doi:10.1007/bf00197420 · Cited by 170
Classification of Pediatric Migraine: Proposed Revisions to the IHS Criteria
Winner, P. K., Martínez, W., Mate, L., et al. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3507407.x · Cited by 152
Self-citationGoodenough, B., Kampel, L., Champion, D. G., Laubreaux, L., Nicholas, K. M., Ziegler, B. J., & McInerney, M. (1997) · Pain · doi:10.1016/s0304-3959(97)00062-6 · Cited by 141
Sumatriptan nasal spray for the acute treatment of migraine
RYAN, R. E., Elkind, A. H., Baker, C. C., Mullican, W. S., DeBussey, S., & Asgharnejad, M. (1997) · Neurology · doi:10.1212/wnl.49.5.1225 · Cited by 138
Self-citationLinder, S. L. (1996) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1996.3607419.x · Cited by 123
Childhood Migraine in General Practice: Clinical Features and Characteristics
Mortimer, M. J., Kay, J., & Jaron, A. G. (1992) · Cephalalgia · doi:10.1046/j.1468-2982.1992.1204238.x · Cited by 112
IHS Criteria for Migraine and Tension‐Type Headache in Children and Adolescents
Wöber‐Bingöl, C., Wöber, C., Wagner-Ennsgraber, C., Karwautz, A. F. K., Vesely, C., Zebenholzer, K., & Geldner, J. (1996) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1996.3604231.x · Cited by 79
Treatment of Juvenile Migraine with Subcutaneous Sumatriptan
MacDonald, J. T. (1994) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1994.hed3410581.x · Cited by 75
Intranasal sumatriptan for the acute treatment of migraine
Salonen, R., Ashford, E., Dahl�f, C., Dawson, R., Gilhus, N. E., L�ben, V., Noronha, D., & Warter, J. (1994) · Journal of Neurology · doi:10.1007/bf00919706 · Cited by 69
How does sumatriptan nasal spray perform in clinical practice?
Dahlöf, C., Boes-Hansen, S., Cederberg, C.-G., Hardebo, J. E., & Henriksson, A. (1998) · Cephalalgia · doi:10.1046/j.1468-2982.1998.1805278.x · Cited by 26
Cited by
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Influences on children’s oral health: A conceptual model
Fisher-Owens, S. A., Gansky, S. A., Platt, L. J., Weintraub, J. A., Soobader, M.-J., Bramlett, M. D., & Newacheck, P. W. (2007) · Pediatrics · doi:10.1542/peds.2006-3084 · Cited by 864
Lewis, D., Ashwal, S., Hershey, A., Hirtz, D., Yonker, M., & Silberstein, S. (2004) · Neurology · doi:10.1212/01.wnl.0000147332.41993.90 · Cited by 440
Analgesics for the Treatment of Pain in Children
Berde, C. B., & Sethna, N. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012626 · Cited by 439
Quality of Life in Childhood Migraines: Clinical Impact and Comparison to Other Chronic Illnesses
Powers, S. W., Patton, S. R., Hommel, K. A., & Hershey, A. D. (2003) · Pediatrics · doi:10.1542/peds.112.1.e1 · Cited by 390
Metadata
- Authors
- Winner, P., Rothner, A. D., Saper, J., Nett, R., Asgharnejad, M., Laurenza, A., Austin, R., & Peykamian, M.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2000-11-01
- Volume
- 106
- Issue
- 5
- Pages
- 989-997
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2051283521
- Cited by
- 281
- References
- 21
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.